Lexaria Bioscience Corp (LXX.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 08/31
(Values in thousands)
| 08-2025 | 08-2024 | 08-2023 | 08-2022 | 08-2021 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 88 | 76 | 145 | 141 | 148 |
| Accounts receivable | -214 | -51 | 27 | -137 | 190 |
| Accounts payable and accrued liabilities | N/A | 826 | 88 | 51 | 14 |
| Other Working Capital | 196 | 107 | 143 | -351 | 64 |
| Other Operating Activity | -10,519 | -5,918 | -6,285 | -4,582 | -4,404 |
| Operating Cash Flow | $-10,450 | $-4,959 | $-5,881 | $-4,879 | $-3,990 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -25 | -43 | -34 | N/A | N/A |
| Purchase Sale Intangibles | -75 | -146 | -136 | -131 | -79 |
| Other Investing Activity | -143 | -146 | -136 | -49 | 273 |
| Investing Cash Flow | $-243 | $-189 | $-170 | $-181 | $194 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | 0 | -45 | -67 |
| Common Stock Issued | 6,046 | 4,209 | 1,590 | 0 | 9,471 |
| Other Financing Activity | 0 | 6,106 | 0 | 0 | 4,015 |
| Financing Cash Flow | $6,046 | $10,315 | $1,590 | $-45 | $13,420 |
| Exchange Rate Effect | -51 | -20 | N/A | N/A | N/A |
| Beginning Cash Position | 6,500 | 1,352 | 5,813 | 10,918 | 1,294 |
| End Cash Position | 1,802 | 6,500 | 1,352 | 5,813 | 10,918 |
| Net Cash Flow | $-4,647 | $5,168 | $-4,461 | $-5,105 | $9,624 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,450 | -4,959 | -5,881 | -4,879 | -3,990 |
| Capital Expenditure | -100 | -189 | -170 | -131 | -79 |
| Free Cash Flow | -10,550 | -5,148 | -6,051 | -5,011 | -4,069 |